XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Balance at the beginning at Dec. 31, 2021 $ 344,747 $ 88 $ 506,760 $ (765) $ (161,336)
Balance at the beginning (in Shares) at Dec. 31, 2021   87,598,184      
Issuance of common stock from exercise of options and employee stock purchase plan 265   265    
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)   111,315      
Stock based compensation expense 3,205   3,205    
Business combination and PIPE financing, issuance costs (8)   (8)    
Other comprehensive income (loss) (2,645)     (2,645)  
Net loss (25,208)       (25,208)
Balance at the ending at Mar. 31, 2022 320,356 $ 88 510,222 (3,410) (186,544)
Balance at the ending (in Shares) at Mar. 31, 2022   87,709,499      
Balance at the beginning at Dec. 31, 2022 249,476 $ 88 522,605 (3,705) (269,512)
Balance at the beginning (in Shares) at Dec. 31, 2022   88,179,374      
Issuance of common stock from exercise of options and employee stock purchase plan 73   73    
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)   30,590      
Stock based compensation expense 4,219   4,219    
Other comprehensive income (loss) 1,504     1,504  
Net loss (28,008)       (28,008)
Balance at the ending at Mar. 31, 2023 $ 227,264 $ 88 $ 526,897 $ (2,201) $ (297,520)
Balance at the ending (in Shares) at Mar. 31, 2023   88,209,964